ADAP Adaptimmune Therapeutics

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Pass Above Fifty Day Moving Average of $1.81

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Rating)'s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.81 and traded as h

08-13 15:51

Analysts Just Made A Major Revision To Their Adaptimmune Therapeutics plc (NASDAQ:ADAP) Revenue Forecasts

Today is shaping up negative for Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. This report focused o

08-10 21:20

European ADRs Move Higher in Tuesday Trading

11:02 AM EDT, 08/09/2022 (MT Newswires) -- American depositary receipts of European stocks were trading 0.35% higher at 1,052.67 on the S&P/BNY Mellon Europe Select ADR Index on Tuesday. In contin

08-09 23:06

European ADRs Move Higher in Monday Trading

11:07 AM EDT, 08/08/2022 (MT Newswires) -- American depositary receipts of European stocks were trading 0.7% higher at 1,055.04 on the S&P/BNY Mellon Europe Select ADR Index on Monday. In continen

08-08 23:09

Adaptimmune Therapeutics (NASDAQ:ADAP) Share Price Passes Above 50-Day Moving Average of $1.71

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Rating) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.71 and traded as h

08-06 23:11

European ADRs Move Lower in Friday Trading

11:14 AM EDT, 08/05/2022 (MT Newswires) -- American depositary receipts of European stocks were trading 0.40% lower at 1,044.25 on the S&P/BNY Mellon Europe Select ADR Index on Friday. In continen

08-05 23:17

Even after rising 23% this past week, Adaptimmune Therapeutics (NASDAQ:ADAP) shareholders are still down 55% over the past five years

Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders will doubtless be very grateful to see the share price up 40% in the last month. But that can't change the reality that over the longer term

08-05 19:20

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

08-05 02:55

European ADRs Move Higher in Thursday Trading

11:06 AM EDT, 08/04/2022 (MT Newswires) -- American depositary receipts of European stocks were trading 0.38% higher at 1,049.11 on the S&P/BNY Mellon Europe Select ADR Index on Thursday. In conti

08-04 23:10

Adaptimmune Therapeutics Earlier Reported Q2 EPS $(0.05) Beats $(0.25) Estimate, Sales $5.54M Miss $6.00M Estimate

Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.25) by 80 percent. This is a 79.17 percent increase over losses o

08-04 22:05